The global compounding pharmacy market is experiencing significant growth due to the increasing demand for hormone replacement therapy (HRT) and the rising adoption of personalized medicine. Additionally, the growing prevalence of chronic diseases that require customized treatment solutions is further driving market expansion.
In line with the latest compounding pharmacy market trends, key players are investing in numerous strategic initiatives aimed at developing growth and increasing their market size. One of the key activities involves substantial investment in research and development (R&D) to improve the quality, efficacy, and safety of compounded drugs.
Through the adoption of sophisticated pharmaceutical technologies and novel drug delivery systems, firms seek to enhance patient compliance and treatment outcomes. Moreover, automation and robotics are increasingly being embraced to simplify compounding procedures for accuracy, effectiveness, and regulatory compliance.
A compounding pharmacy is a pharmacy that compiles customized drugs to meet the unique needs of a specific patient. Compounding pharmacies differ from traditional pharmacies in that they blend or alter ingredients to create a personalized drug.
Altering the dosage, changing the form (e.g., transforming it into liquid, cream, or suppository), or creating drugs that are not mass-produced or stocked in traditional pharmacies is all that a compounding pharmacy does.
Compounding pharmacies treat patients who require medication that is not commercially prepared, for example, patients with allergy to certain ingredients or patients who require a specific dosage form or strength. They are able to prepare steril or non-steril preparations based on the patient. Some only prepare one of them, but others prepare both.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
The increasing need for hormone replacement therapy (HRT) is expected to have a significant impact on the growth of the compounding pharmacy market, as it is leading to the development of more customized therapies. With more patients needing personalized hormone therapies that are not available in standard commercial preparations, compounding pharmacies have become essential.
These pharmacies offer many individualized options, including specialty dosages, delivery methods, and hormone combinations, that can better meet the patients' requirements. This is especially crucial for patients who are dealing with conditions such as menopause, andropause, or other hormonal imbalances where traditional treatment may be insufficient.
In addition, as more individuals become aware of the potential benefits of compounded hormone replacement therapy, particularly bioidentical hormone therapy, demand for such specialized services is bound to grow. Bioidentical hormones, since they are chemically identical to the hormones produced naturally by the body, offer an appealing alternative to synthetic hormones.
Their growing use is boosting the demand for personalized medicine, whereby treatment is tailored specifically to the patient's biological profile. Bioidentical hormones are primarily preferred due to their presumed efficacy and safety, and they represent one of the key drivers of the compounding pharmacy market expansion.
The compounding pharmacy market share is bolstering rapidly with a boost from the evolution of customized medicine. This trend individualizes treatment to specific patients based on genetic predisposition, health background, and lifestyle.
Compounding pharmacies play a crucial role through their capacity to provide customized medications that are different from mass-produced pharmaceuticals, enabling precise dosage, alternative administration routes, and changed formulation.
An example of such is precision medicine in oncology. In October 2024, the NIH launched a clinical trial to examine targeted therapies for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). As there is increasing need for personalized cancer treatments, compounding pharmacies are becoming key suppliers of tailored medication solutions.
Compounding pharmacies also bridge gaps in traditional pharmaceuticals by reformulating drugs, breaking tablets into liquid forms, and changing dosages for patient-specific needs. These capabilities are beneficial for patients with chronic pain, hormonal imbalances, and pediatric disorders.
Although an increased demand for precision medicine exists, compounding pharmacy services will continue to expand. Advances in pharmaceutical technology and regulatory support further drive compounding pharmacy market growth, positioning compounding pharmacies as vital to the future of personalized healthcare.
A 503A compounding pharmacy compounds or alters medications written by physicians for patients whose requirements are not possible with available commercially marketed drugs. The pharmacies are mostly located in hospitals and retail stores, and they serve patients who are unable to tolerate usual dosage forms or have an allergy to a particular ingredient.
The 503B compounding pharmacy industry is growing as a result of the demand for outsourced drugs, drug shortages, greater patient safety awareness, and greater emphasis on quality and compliance. Moreover, the expansion of compounding networks is fueling this market segment.
For instance, in September 2024, Revelation Pharma extended its compounding network across the country, introducing a national wholesale service for healthcare providers, further enhancing access to customized medications.
The pharmaceutical manufacturing segment during drug shortages retains the largest part of the market for compounding pharmacies due to the growing incidences of drug shortages, demands for tailored medicine, the upsurge of demand for personal medicine, and increased production capabilities.
As per USP's 2024 Annual Drug Shortages Report, shortages persist on average for three years, with more than half of them targeting generic sterile injectables—a segment that has a great impact on health systems. Economic considerations, specifically low drug prices, have been cited as primary drivers, as they deter manufacturer participation, further driving supply issues.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest compounding pharmacy market analysis, North Americas held the largest share in 2024. Increasing demand for customized medicine, a strong healthcare infrastructure, technological innovation, and changing consumer preferences some of the factors driving the market.
The increasing incidence of chronic illnesses like diabetes, high blood pressure, and arthritis further fuels the need for personalized medications that respond to intricate therapeutic requirements.
A compounding pharmacy compiles medicines prescribed by physicians for patients with needs that cannot be fulfilled by mass-produced drugs. Pharmacists tailor treatments for dermatological disorders, orphan diseases, and other unique requirements, as long as the drug is not available from a drug company.
In the U.S., according to the International Academy of Compounding Pharmacists (IACP), there are 56,000 community pharmacies, half of which directly provide service to local physicians and patients. There are also 7,500 pharmacies specializing in higher compounding services, of which 3,000 manufacture sterile products.
Key players operating in the global industry are collaborating with biopharmaceutical firms, contract development and manufacturing organizations (CDMOs), and research institutions to enhance their compounding pharmacy services.
Walgreen Co., Wedgewood Pharmacy, Fagron, Fresenius Kabi AG, B. Braun Melsungen AG, Albertsons Companies, Inc., Optum, Inc., Fusion Apothecary, Hill’s Compounding Pharmacy, The London Specialist Pharmacy Ltd., Aurora Health Care, Triangle Compounding, Roseway Labs, are some of the prominent compounding pharmacy market players.
Each of these players has been have been profiled in the compounding pharmacy market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2023 | US$ 13,474.6 Mn |
| Forecast Value in 2034 | More than US$ 26,838.8 Mn |
| CAGR | 6.5% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2023 |
| Quantitative Units | US$ Mn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The global compounding pharmacy market was valued at US$ 13,474.6 Mn in 2023.
Compounding pharmacy business is projected to cross US$ 26,838.8 Mn by the end of 2034.
Increasing demand for hormone replacement therapy (HRT) and the rising adoption of personalized medicine.
The CAGR is anticipated to be 6.5% from 2024 to 2034.
North America is expected to account for the largest share from 2024 to 2034.
Walgreen Co., Wedgewood Pharmacy, Fagron, Fresenius Kabi AG, B. Braun Melsungen AG, Albertsons Companies, Inc., Optum, Inc., Fusion Apothecary, Hill’s Compounding Pharmacy, The London Specialist Pharmacy Ltd., Aurora Health Care, Triangle Compounding, and Roseway Labs.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Compounding Pharmacy Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Compounding Pharmacy Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements that assist Pharmaceutical Compounding
5.2. Insights on In-house and Outsourced Pharmaceutical Compounding
5.3. Discussion on Benefits and Potential Risks of Pharmaceutical Compounding
5.4. List of Compounding Pharmacies across Key Region / Countries
5.5. Regulatory Scenario across Key Regions / Countries
5.6. PORTER’s Five Forces Analysis
5.7. PESTEL Analysis
5.8. Value Chain Analysis
5.9. Go-to-Market Strategy for New Market Entrants
5.10. Key Industry Events
6. Global Compounding Pharmacy Market Analysis and Forecasts, By Pharmacy Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Pharmacy Type, 2020-2034
6.3.1. 503A Pharmacies
6.3.2. 503B Pharmacies
6.4. Market Attractiveness By Pharmacy Type
7. Global Compounding Pharmacy Market Analysis and Forecasts, By Compounding Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Compounding Type, 2020-2034
7.3.1. Pharmaceutical Ingredient Alteration (PIA)
7.3.2. Drug Shortage Manufacturing
7.3.3. Pharmaceutical Dosage Alteration (PDA)
7.4. Market Attractiveness By Compounding Type
8. Global Compounding Pharmacy Market Analysis and Forecasts, By Sterility
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Sterility, 2020-2034
8.3.1. Sterile
8.3.2. Non-sterile
8.4. Market Attractiveness By Sterility
9. Global Compounding Pharmacy Market Analysis and Forecasts, By Dosage Form
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By Dosage Form, 2020-2034
9.3.1. Oral Medications
9.3.1.1. Capsules
9.3.1.2. Tablets
9.3.1.3. Suspensions
9.3.1.4. Others (Chewables, etc.)
9.3.2. Topical Medications
9.3.2.1. Creams
9.3.2.2. Gels
9.3.2.3. Ointments
9.3.2.4. Others (Paste, etc.)
9.3.3. Injectables
9.3.4. Suppositories
9.3.5. Others
9.4. Market Attractiveness By Dosage Form
10. Global Compounding Pharmacy Market Analysis and Forecasts, By Application
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast By Application, 2020-2034
10.3.1. Hormone Replacement Therapy
10.3.2. Pain Management
10.3.3. Neurology
10.3.4. Dermatology
10.3.5. Ophthalmology
10.3.6. Nutritional Supplements
10.3.7. Others (ENT, Thyroid Disorders, etc.)
10.4. Market Attractiveness By Application
11. Global Compounding Pharmacy Market Analysis and Forecasts, By Patient Demographics
11.1. Introduction & Definition
11.2. Key Findings / Developments
11.3. Market Value Forecast By Patient Demographics, 2020-2034
11.3.1. Human
11.3.1.1. Pediatric
11.3.1.2. Adult
11.3.1.3. Geriatric
11.3.2. Veterinary
11.4. Market Attractiveness By Patient Demographics
12. Global Compounding Pharmacy Market Analysis and Forecasts, By Region
12.1. Key Findings
12.2. Market Value Forecast By Region
12.2.1. North America
12.2.2. Europe
12.2.3. Asia Pacific
12.2.4. Latin America
12.2.5. Middle East & Africa
12.3. Market Attractiveness By Country/Region
13. North America Compounding Pharmacy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Pharmacy Type, 2020-2034
13.2.1. 503A Pharmacies
13.2.2. 503B Pharmacies
13.3. Market Value Forecast By Compounding Type, 2020-2034
13.3.1. Pharmaceutical Ingredient Alteration (PIA)
13.3.2. Drug Shortage Manufacturing
13.3.3. Pharmaceutical Dosage Alteration (PDA)
13.4. Market Value Forecast By Sterility, 2020-2034
13.4.1. Sterile
13.4.2. Non-sterile
13.5. Market Value Forecast By Dosage Form, 2020-2034
13.5.1. Oral Medications
13.5.1.1. Capsules
13.5.1.2. Tablets
13.5.1.3. Suspensions
13.5.1.4. Others (Chewables, etc.)
13.5.2. Topical Medications
13.5.2.1. Creams
13.5.2.2. Gels
13.5.2.3. Ointments
13.5.2.4. Others (Paste, etc.)
13.5.3. Injectables
13.5.4. Suppositories
13.5.5. Others
13.6. Market Value Forecast By Application, 2020-2034
13.6.1. Hormone Replacement Therapy
13.6.2. Pain Management
13.6.3. Neurology
13.6.4. Dermatology
13.6.5. Ophthalmology
13.6.6. Nutritional Supplements
13.6.7. Others (ENT, Thyroid Disorders, etc.)
13.7. Market Value Forecast By Patient Demographics, 2020-2034
13.7.1. Human
13.7.1.1. Pediatric
13.7.1.2. Adult
13.7.1.3. Geriatric
13.7.2. Veterinary
13.8. Market Value Forecast By Country, 2020-2034
13.8.1. U.S.
13.8.2. Canada
13.9. Market Attractiveness Analysis
13.9.1. By Pharmacy Type
13.9.2. By Compounding Type
13.9.3. By Sterility
13.9.4. By Dosage Form
13.9.5. By Application
13.9.6. By Patient Demographics
13.9.7. By Country
14. Europe Compounding Pharmacy Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Pharmacy Type, 2020-2034
14.2.1. 503A Pharmacies
14.2.2. 503B Pharmacies
14.3. Market Value Forecast By Compounding Type, 2020-2034
14.3.1. Pharmaceutical Ingredient Alteration (PIA)
14.3.2. Drug Shortage Manufacturing
14.3.3. Pharmaceutical Dosage Alteration (PDA)
14.4. Market Value Forecast By Sterility, 2020-2034
14.4.1. Sterile
14.4.2. Non-sterile
14.5. Market Value Forecast By Dosage Form, 2020-2034
14.5.1. Oral Medications
14.5.1.1. Capsules
14.5.1.2. Tablets
14.5.1.3. Suspensions
14.5.1.4. Others (Chewables, etc.)
14.5.2. Topical Medications
14.5.2.1. Creams
14.5.2.2. Gels
14.5.2.3. Ointments
14.5.2.4. Others (Paste, etc.)
14.5.3. Injectables
14.5.4. Suppositories
14.5.5. Others
14.6. Market Value Forecast By Application, 2020-2034
14.6.1. Hormone Replacement Therapy
14.6.2. Pain Management
14.6.3. Neurology
14.6.4. Dermatology
14.6.5. Ophthalmology
14.6.6. Nutritional Supplements
14.6.7. Others (ENT, Thyroid Disorders, etc.)
14.7. Market Value Forecast By Patient Demographics, 2020-2034
14.7.1. Human
14.7.1.1. Pediatric
14.7.1.2. Adult
14.7.1.3. Geriatric
14.7.2. Veterinary
14.8. Market Value Forecast By Country/Sub-region, 2020-2034
14.8.1. Germany
14.8.2. U.K.
14.8.3. France
14.8.4. Italy
14.8.5. Spain
14.8.6. Rest of Europe
14.9. Market Attractiveness Analysis
14.9.1. By Pharmacy Type
14.9.2. By Compounding Type
14.9.3. By Sterility
14.9.4. By Dosage Form
14.9.5. By Application
14.9.6. By Patient Demographics
14.9.7. By Country/Sub-region
15. Asia Pacific Compounding Pharmacy Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Pharmacy Type, 2020-2034
15.2.1. 503A Pharmacies
15.2.2. 503B Pharmacies
15.3. Market Value Forecast By Compounding Type, 2020-2034
15.3.1. Pharmaceutical Ingredient Alteration (PIA)
15.3.2. Drug Shortage Manufacturing
15.3.3. Pharmaceutical Dosage Alteration (PDA)
15.4. Market Value Forecast By Sterility, 2020-2034
15.4.1. Sterile
15.4.2. Non-sterile
15.5. Market Value Forecast By Dosage Form, 2020-2034
15.5.1. Oral Medications
15.5.1.1. Capsules
15.5.1.2. Tablets
15.5.1.3. Suspensions
15.5.1.4. Others (Chewables, etc.)
15.5.2. Topical Medications
15.5.2.1. Creams
15.5.2.2. Gels
15.5.2.3. Ointments
15.5.2.4. Others (Paste, etc.)
15.5.3. Injectables
15.5.4. Suppositories
15.5.5. Others
15.6. Market Value Forecast By Application, 2020-2034
15.6.1. Hormone Replacement Therapy
15.6.2. Pain Management
15.6.3. Neurology
15.6.4. Dermatology
15.6.5. Ophthalmology
15.6.6. Sports Medicine
15.6.7. Nutritional Supplements
15.6.8. Others (ENT, Thyroid Disorders, etc.)
15.7. Market Value Forecast By Patient Demographics, 2020-2034
15.7.1. Human
15.7.1.1. Pediatric
15.7.1.2. Adult
15.7.1.3. Geriatric
15.7.2. Veterinary
15.8. Market Value Forecast By Country/Sub-region, 2020-2034
15.8.1. China
15.8.2. India
15.8.3. Japan
15.8.4. Australia & New Zealand
15.8.5. Rest of Asia Pacific
15.9. Market Attractiveness Analysis
15.9.1. By Pharmacy Type
15.9.2. By Compounding Type
15.9.3. By Sterility
15.9.4. By Dosage Form
15.9.5. By Application
15.9.6. By Patient Demographics
15.9.7. By Country/Sub-region
16. Latin America Compounding Pharmacy Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast By Pharmacy Type, 2020-2034
16.2.1. 503A Pharmacies
16.2.2. 503B Pharmacies
16.3. Market Value Forecast By Compounding Type, 2020-2034
16.3.1. Pharmaceutical Ingredient Alteration (PIA)
16.3.2. Drug Shortage Manufacturing
16.3.3. Pharmaceutical Dosage Alteration (PDA)
16.4. Market Value Forecast By Sterility, 2020-2034
16.4.1. Sterile
16.4.2. Non-sterile
16.5. Market Value Forecast By Dosage Form, 2020-2034
16.5.1. Oral Medications
16.5.1.1. Capsules
16.5.1.2. Tablets
16.5.1.3. Suspensions
16.5.1.4. Others (Chewables, etc.)
16.5.2. Topical Medications
16.5.2.1. Creams
16.5.2.2. Gels
16.5.2.3. Ointments
16.5.2.4. Others (Paste, etc.)
16.5.3. Injectables
16.5.4. Suppositories
16.5.5. Others
16.6. Market Value Forecast By Application, 2020-2034
16.6.1. Hormone Replacement Therapy
16.6.2. Pain Management
16.6.3. Neurology
16.6.4. Dermatology
16.6.5. Ophthalmology
16.6.6. Nutritional Supplements
16.6.7. Others (ENT, Thyroid Disorders, etc.)
16.7. Market Value Forecast By Patient Demographics, 2020-2034
16.7.1. Human
16.7.1.1. Pediatric
16.7.1.2. Adult
16.7.1.3. Geriatric
16.7.2. Veterinary
16.8. Market Value Forecast By Country/Sub-region, 2020-2034
16.8.1. Brazil
16.8.2. Mexico
16.8.3. Rest of Latin America
16.9. Market Attractiveness Analysis
16.9.1. By Pharmacy Type
16.9.2. By Compounding Type
16.9.3. By Sterility
16.9.4. By Dosage Form
16.9.5. By Application
16.9.6. By Patient Demographics
16.9.7. By Country/Sub-region
17. Middle East & Africa Compounding Pharmacy Market Analysis and Forecast
17.1. Introduction
17.1.1. Key Findings
17.2. Market Value Forecast By Pharmacy Type, 2020-2034
17.2.1. 503A Pharmacies
17.2.2. 503B Pharmacies
17.3. Market Value Forecast By Compounding Type, 2020-2034
17.3.1. Pharmaceutical Ingredient Alteration (PIA)
17.3.2. Drug Shortage Manufacturing
17.3.3. Pharmaceutical Dosage Alteration (PDA)
17.4. Market Value Forecast By Sterility, 2020-2034
17.4.1. Sterile
17.4.2. Non-sterile
17.5. Market Value Forecast By Dosage Form, 2020-2034
17.5.1. Oral Medications
17.5.1.1. Capsules
17.5.1.2. Tablets
17.5.1.3. Suspensions
17.5.1.4. Others (Chewables, etc.)
17.5.2. Topical Medications
17.5.2.1. Creams
17.5.2.2. Gels
17.5.2.3. Ointments
17.5.2.4. Others (Paste, etc.)
17.5.3. Injectables
17.5.4. Suppositories
17.5.5. Others
17.6. Market Value Forecast By Application, 2020-2034
17.6.1. Hormone Replacement Therapy
17.6.2. Pain Management
17.6.3. Neurology
17.6.4. Dermatology
17.6.5. Ophthalmology
17.6.6. Nutritional Supplements
17.6.7. Others (ENT, Thyroid Disorders, etc.)
17.7. Market Value Forecast By Patient Demographics, 2020-2034
17.7.1. Human
17.7.1.1. Pediatric
17.7.1.2. Adult
17.7.1.3. Geriatric
17.7.2. Veterinary
17.8. Market Value Forecast By Country/Sub-region, 2020-2034
17.8.1. GCC Countries
17.8.2. South Africa
17.8.3. Rest of Middle East & Africa
17.9. Market Attractiveness Analysis
17.9.1. By Pharmacy Type
17.9.2. By Compounding Type
17.9.3. By Sterility
17.9.4. By Dosage Form
17.9.5. By Application
17.9.6. By Patient Demographics
17.9.7. By Country/Sub-region
18. Competition Landscape
18.1. Market Player - Competition Matrix (By Tier and Size of companies)
18.2. Market Share Analysis By Company (2023)
18.3. Company Profiles
18.3.1. B. Braun SE
18.3.1.1. Company Overview
18.3.1.2. Financial Overview
18.3.1.3. Financial Overview
18.3.1.4. Business Strategies
18.3.1.5. Recent Developments
18.3.2. WEDGEWOOD PHARMACY
18.3.2.1. Company Overview
18.3.2.2. Financial Overview
18.3.2.3. Financial Overview
18.3.2.4. Business Strategies
18.3.2.5. Recent Developments
18.3.3. Fagron
18.3.3.1. Company Overview
18.3.3.2. Financial Overview
18.3.3.3. Financial Overview
18.3.3.4. Business Strategies
18.3.3.5. Recent Developments
18.3.4. Fresenius Kabi AG
18.3.4.1. Company Overview
18.3.4.2. Financial Overview
18.3.4.3. Financial Overview
18.3.4.4. Business Strategies
18.3.4.5. Recent Developments
18.3.5. Avella Specialty Pharmacy
18.3.5.1. Company Overview
18.3.5.2. Financial Overview
18.3.5.3. Financial Overview
18.3.5.4. Business Strategies
18.3.5.5. Recent Developments
18.3.6. Aurora Health Care
18.3.6.1. Company Overview
18.3.6.2. Financial Overview
18.3.6.3. Financial Overview
18.3.6.4. Business Strategies
18.3.6.5. Recent Developments
18.3.7. Walgreen Co.
18.3.7.1. Company Overview
18.3.7.2. Financial Overview
18.3.7.3. Financial Overview
18.3.7.4. Business Strategies
18.3.7.5. Recent Developments
18.3.8. Formul8
18.3.8.1. Company Overview
18.3.8.2. Financial Overview
18.3.8.3. Financial Overview
18.3.8.4. Business Strategies
18.3.8.5. Recent Developments
18.3.9. Triangle Compounding
18.3.9.1. Company Overview
18.3.9.2. Financial Overview
18.3.9.3. Financial Overview
18.3.9.4. Business Strategies
18.3.9.5. Recent Developments
18.3.10. Apollo Clinical Pharmacy
18.3.10.1. Company Overview
18.3.10.2. Financial Overview
18.3.10.3. Financial Overview
18.3.10.4. Business Strategies
18.3.10.5. Recent Developments
18.3.11. The London Specialist Pharmacy Ltd
18.3.11.1. Company Overview
18.3.11.2. Financial Overview
18.3.11.3. Financial Overview
18.3.11.4. Business Strategies
18.3.11.5. Recent Developments
18.3.12. Olympia Pharmacy
18.3.12.1. Company Overview
18.3.12.2. Financial Overview
18.3.12.3. Financial Overview
18.3.12.4. Business Strategies
18.3.12.5. Recent Developments
18.3.13. Fusion Apothecary
18.3.13.1. Company Overview
18.3.13.2. Financial Overview
18.3.13.3. Financial Overview
18.3.13.4. Business Strategies
18.3.13.5. Recent Developments
18.3.14. Albertsons Companies, Inc.
18.3.14.1. Company Overview
18.3.14.2. Financial Overview
18.3.14.3. Financial Overview
18.3.14.4. Business Strategies
18.3.14.5. Recent Developments
18.3.15. JL Diekman and AQ Touchard
18.3.15.1. Company Overview
18.3.15.2. Financial Overview
18.3.15.3. Financial Overview
18.3.15.4. Business Strategies
18.3.15.5. Recent Developments
18.3.16. Roseway Labs
18.3.16.1. Company Overview
18.3.16.2. Financial Overview
18.3.16.3. Financial Overview
18.3.16.4. Business Strategies
18.3.16.5. Recent Developments
18.3.17. Hill’s Compounding Pharmacy and Milford Pharmacy
18.3.17.1. Company Overview
18.3.17.2. Financial Overview
18.3.17.3. Financial Overview
18.3.17.4. Business Strategies
18.3.17.5. Recent Developments
18.3.18. Other Prominent Players
18.3.18.1. Company Overview
18.3.18.2. Financial Overview
18.3.18.3. Financial Overview
18.3.18.4. Business Strategies
18.3.18.5. Recent Developments
List of Tables
Table 01: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Pharmacy Type, 2020-2034
Table 02: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Compounding Type, 2020-2034
Table 03: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Sterility, 2020-2034
Table 04: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Dosage Form, 2020-2034
Table 05: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Oral Medications, 2020-2034
Table 06: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Topical Medications, 2020-2034
Table 07: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Application, 2020-2034
Table 08: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Patient Demographics, 2020-2034
Table 09: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Human, 2020-2034
Table 10: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Region, 2020-2034
Table 11: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 12: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Pharmacy Type, 2020-2034
Table 13: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Compounding Type, 2020-2034
Table 14: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Sterility, 2020-2034
Table 15: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Dosage Form, 2020-2034
Table 16: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Oral Medications, 2020-2034
Table 17: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Topical Medications, 2020-2034
Table 18: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2034
Table 19: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Patient Demographics, 2020-2034
Table 20: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Human, 2020-2034
Table 21: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 22: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Pharmacy Type, 2020-2034
Table 23: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Compounding Type, 2020-2034
Table 24: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Sterility, 2020-2034
Table 25: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Dosage Form, 2020-2034
Table 26: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Oral Medications, 2020-2034
Table 27: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Topical Medications, 2020-2034
Table 28: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Application, 2020-2034
Table 29: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Patient Demographics, 2020-2034
Table 30: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Human, 2020-2034
Table 31: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 32: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Pharmacy Type, 2020-2034
Table 33: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Compounding Type, 2020-2034
Table 34: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Sterility, 2020-2034
Table 35: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Dosage Form, 2020-2034
Table 36: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Oral Medications, 2020-2034
Table 37: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Topical Medications, 2020-2034
Table 38: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Application, 2020-2034
Table 39: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Patient Demographics, 2020-2034
Table 40: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Human, 2020-2034
Table 41: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 42: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Pharmacy Type, 2020-2034
Table 43: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Compounding Type, 2020-2034
Table 44: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Sterility, 2020-2034
Table 45: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Dosage Form, 2020-2034
Table 46: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Oral Medications, 2020-2034
Table 47: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Topical Medications, 2020-2034
Table 48: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Application, 2020-2034
Table 49: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Patient Demographics, 2020-2034
Table 50: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Human, 2020-2034
Table 51: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Country, 2020-2034
Table 52: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Pharmacy Type, 2020-2034
Table 53: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Compounding Type, 2020-2034
Table 54: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Sterility, 2020-2034
Table 55: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Dosage Form, 2020-2034
Table 56: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Oral Medications, 2020-2034
Table 57: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Topical Medications, 2020-2034
Table 58: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Application, 2020-2034
Table 59: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Patient Demographics, 2020-2034
Table 60: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Human, 2020-2034
List of Figures
Figure 01: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, by Region, 2020-2034
Figure 02: Global Compounding Pharmacy Market Value Share Analysis, By Pharmacy Type, 2023 and 2034
Figure 03: Global Compounding Pharmacy Market Attractiveness Analysis, By Pharmacy Type, 2024-2034
Figure 04: Global Compounding Pharmacy Market Revenue (US$ Mn), by 503A Pharmacies, 2020-2034
Figure 05: Global Compounding Pharmacy Market Revenue (US$ Mn), by 503B Pharmacies, 2020-2034
Figure 06: Global Compounding Pharmacy Market Value Share Analysis, By Compounding Type, 2023 and 2034
Figure 07: Global Compounding Pharmacy Market Attractiveness Analysis, By Compounding Type, 2024-2034
Figure 08: Global Compounding Pharmacy Market Revenue (US$ Mn), by Pharmaceutical Ingredient Alteration (PIA), 2020-2034
Figure 09: Global Compounding Pharmacy Market Revenue (US$ Mn), by Drug Shortage Manufacturing, 2020-2034
Figure 10: Global Compounding Pharmacy Market Revenue (US$ Mn), by Pharmaceutical Dosage Alteration (PDA), 2020-2034
Figure 11: Global Compounding Pharmacy Market Value Share Analysis, By Sterility, 2023 and 2034
Figure 12: Global Compounding Pharmacy Market Attractiveness Analysis, By Sterility, 2024-2034
Figure 13: Global Compounding Pharmacy Market Revenue (US$ Mn), by Sterile, 2020-2034
Figure 14: Global Compounding Pharmacy Market Revenue (US$ Mn), by Non-sterile, 2020-2034
Figure 15: Global Compounding Pharmacy Market Value Share Analysis, By Dosage Form, 2023 and 2034
Figure 16: Global Compounding Pharmacy Market Attractiveness Analysis, By Dosage Form, 2024-2034
Figure 17: Global Compounding Pharmacy Market Revenue (US$ Mn), by Oral Medications, 2020-2034
Figure 18: Global Compounding Pharmacy Market Revenue (US$ Mn), by Topical Medications, 2020-2034
Figure 19: Global Compounding Pharmacy Market Revenue (US$ Mn), by Injectables, 2020-2034
Figure 20: Global Compounding Pharmacy Market Revenue (US$ Mn), by Suppositories, 2020-2034
Figure 21: Global Compounding Pharmacy Market Revenue (US$ Mn), by Others, 2020-2034
Figure 22: Global Compounding Pharmacy Market Value Share Analysis, By Application, 2023 and 2034
Figure 23: Global Compounding Pharmacy Market Attractiveness Analysis, By Application, 2024-2034
Figure 24: Global Compounding Pharmacy Market Revenue (US$ Mn), by Hormone Replacement Therapy, 2020-2034
Figure 25: Global Compounding Pharmacy Market Revenue (US$ Mn), by Dermatology & Wound Care, 2020-2034
Figure 26: Global Compounding Pharmacy Market Revenue (US$ Mn), by Pain Management, 2020-2034
Figure 27: Global Compounding Pharmacy Market Revenue (US$ Mn), by Ophthalmology, 2020-2034
Figure 28: Global Compounding Pharmacy Market Revenue (US$ Mn), by Neurology, 2020-2034
Figure 29: Global Compounding Pharmacy Market Revenue (US$ Mn), by Nutritional Supplements, 2020-2034
Figure 30: Global Compounding Pharmacy Market Revenue (US$ Mn), by Others, 2020-2034
Figure 31: Global Compounding Pharmacy Market Value Share Analysis, By Patient Demographics, 2023 and 2034
Figure 32: Global Compounding Pharmacy Market Attractiveness Analysis, By Patient Demographics, 2024-2034
Figure 33: Global Compounding Pharmacy Market Revenue (US$ Mn), by Human, 2020-2034
Figure 34: Global Compounding Pharmacy Market Revenue (US$ Mn), by Veterinary, 2020-2034
Figure 35: Global Compounding Pharmacy Market Value Share Analysis, By Region, 2023 and 2034
Figure 36: Global Compounding Pharmacy Market Attractiveness Analysis, By Region, 2024-2034
Figure 37: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, 2020-2034
Figure 38: North America - Compounding Pharmacy Market Value Share Analysis, by Country, 2023 and 2034
Figure 39: North America - Compounding Pharmacy Market Attractiveness Analysis, by Country, 2024-2034
Figure 40: North America Compounding Pharmacy Market Value Share Analysis, By Pharmacy Type, 2023 and 2034
Figure 41: North America Compounding Pharmacy Market Attractiveness Analysis, By Pharmacy Type, 2024-2034
Figure 42: North America - Compounding Pharmacy Market Value Share Analysis, By Compounding Type, 2023 and 2034
Figure 43: North America - Compounding Pharmacy Market Attractiveness Analysis, By Compounding Type, 2024-2034
Figure 44: North America - Compounding Pharmacy Market Value Share Analysis, By Sterility, 2023 and 2034
Figure 45: North America - Compounding Pharmacy Market Attractiveness Analysis, By Sterility, 2024-2034
Figure 46: North America - Compounding Pharmacy Market Value Share Analysis, By Dosage Form, 2023 and 2034
Figure 47: North America - Compounding Pharmacy Market Attractiveness Analysis, By Dosage Form, 2024-2034
Figure 48: North America - Compounding Pharmacy Market Value Share Analysis, By Application, 2023 and 2034
Figure 49: North America - Compounding Pharmacy Market Attractiveness Analysis, By Application, 2024-2034
Figure 50: North America - Compounding Pharmacy Market Value Share Analysis, By Patient Demographics, 2023 and 2034
Figure 51: North America - Compounding Pharmacy Market Attractiveness Analysis, By Patient Demographics, 2024-2034
Figure 52: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, 2020-2034
Figure 53: Europe - Compounding Pharmacy Market Value Share Analysis, by Country, 2023 and 2034
Figure 54: Europe - Compounding Pharmacy Market Attractiveness Analysis, by Country, 2024-2034
Figure 55: Europe Compounding Pharmacy Market Value Share Analysis, By Pharmacy Type, 2023 and 2034
Figure 56: Europe Compounding Pharmacy Market Attractiveness Analysis, By Pharmacy Type, 2024-2034
Figure 57: Europe - Compounding Pharmacy Market Value Share Analysis, By Compounding Type, 2023 and 2034
Figure 58: Europe - Compounding Pharmacy Market Attractiveness Analysis, By Compounding Type, 2024-2034
Figure 59: Europe - Compounding Pharmacy Market Value Share Analysis, By Sterility, 2023 and 2034
Figure 60: Europe - Compounding Pharmacy Market Attractiveness Analysis, By Sterility, 2024-2034
Figure 61: Europe - Compounding Pharmacy Market Value Share Analysis, By Dosage Form, 2023 and 2034
Figure 62: Europe - Compounding Pharmacy Market Attractiveness Analysis, By Dosage Form, 2024-2034
Figure 63: Europe - Compounding Pharmacy Market Value Share Analysis, By Application, 2023 and 2034
Figure 64: Europe - Compounding Pharmacy Market Attractiveness Analysis, By Application, 2024-2034
Figure 65: Europe - Compounding Pharmacy Market Value Share Analysis, By Patient Demographics, 2023 and 2034
Figure 66: Europe - Compounding Pharmacy Market Attractiveness Analysis, By Patient Demographics, 2024-2034
Figure 67: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, 2020-2034
Figure 68: Asia Pacific - Compounding Pharmacy Market Value Share Analysis, by Country, 2023 and 2034
Figure 69: Asia Pacific - Compounding Pharmacy Market Attractiveness Analysis, by Country, 2024-2034
Figure 70: Asia Pacific Compounding Pharmacy Market Value Share Analysis, By Pharmacy Type, 2023 and 2034
Figure 71: Asia Pacific Compounding Pharmacy Market Attractiveness Analysis, By Pharmacy Type, 2024-2034
Figure 72: Asia Pacific - Compounding Pharmacy Market Value Share Analysis, By Compounding Type, 2023 and 2034
Figure 73: Asia Pacific - Compounding Pharmacy Market Attractiveness Analysis, By Compounding Type, 2024-2034
Figure 74: Asia Pacific - Compounding Pharmacy Market Value Share Analysis, By Sterility, 2023 and 2034
Figure 75: Asia Pacific - Compounding Pharmacy Market Attractiveness Analysis, By Sterility, 2024-2034
Figure 76: Asia Pacific - Compounding Pharmacy Market Value Share Analysis, By Dosage Form, 2023 and 2034
Figure 77: Asia Pacific - Compounding Pharmacy Market Attractiveness Analysis, By Dosage Form, 2024-2034
Figure 78: Asia Pacific - Compounding Pharmacy Market Value Share Analysis, By Application, 2023 and 2034
Figure 79: Asia Pacific - Compounding Pharmacy Market Attractiveness Analysis, By Application, 2024-2034
Figure 80: Asia Pacific - Compounding Pharmacy Market Value Share Analysis, By Patient Demographics, 2023 and 2034
Figure 81: Asia Pacific - Compounding Pharmacy Market Attractiveness Analysis, By Patient Demographics, 2024-2034
Figure 82: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, 2020-2034
Figure 83: Latin America - Compounding Pharmacy Market Value Share Analysis, by Country, 2023 and 2034
Figure 84: Latin America - Compounding Pharmacy Market Attractiveness Analysis, by Country, 2024-2034
Figure 85: Latin America Compounding Pharmacy Market Value Share Analysis, By Pharmacy Type, 2023 and 2034
Figure 86: Latin America Compounding Pharmacy Market Attractiveness Analysis, By Pharmacy Type, 2024-2034
Figure 87: Latin America - Compounding Pharmacy Market Value Share Analysis, By Compounding Type, 2023 and 2034
Figure 88: Latin America - Compounding Pharmacy Market Attractiveness Analysis, By Compounding Type, 2024-2034
Figure 89: Latin America - Compounding Pharmacy Market Value Share Analysis, By Sterility, 2023 and 2034
Figure 90: Latin America - Compounding Pharmacy Market Attractiveness Analysis, By Sterility, 2024-2034
Figure 91: Latin America - Compounding Pharmacy Market Value Share Analysis, By Dosage Form, 2023 and 2034
Figure 92: Latin America - Compounding Pharmacy Market Attractiveness Analysis, By Dosage Form, 2024-2034
Figure 93: Latin America - Compounding Pharmacy Market Value Share Analysis, By Application, 2023 and 2034
Figure 94: Latin America - Compounding Pharmacy Market Attractiveness Analysis, By Application, 2024-2034
Figure 95: Latin America - Compounding Pharmacy Market Value Share Analysis, By Patient Demographics, 2023 and 2034
Figure 96: Latin America - Compounding Pharmacy Market Attractiveness Analysis, By Patient Demographics, 2024-2034
Figure 97: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, 2020-2034
Figure 98: Middle East and Africa - Compounding Pharmacy Market Value Share Analysis, by Country, 2023 and 2034
Figure 99: Middle East and Africa - Compounding Pharmacy Market Attractiveness Analysis, by Country, 2024-2034
Figure 100: Middle East and Africa Compounding Pharmacy Market Value Share Analysis, By Pharmacy Type, 2023 and 2034
Figure 101: Middle East and Africa Compounding Pharmacy Market Attractiveness Analysis, By Pharmacy Type, 2024-2034
Figure 102: Middle East and Africa - Compounding Pharmacy Market Value Share Analysis, By Compounding Type, 2023 and 2034
Figure 103: Middle East and Africa - Compounding Pharmacy Market Attractiveness Analysis, By Compounding Type, 2024-2034
Figure 104: Middle East and Africa - Compounding Pharmacy Market Value Share Analysis, By Sterility, 2023 and 2034
Figure 105: Middle East and Africa - Compounding Pharmacy Market Attractiveness Analysis, By Sterility, 2024-2034
Figure 106: Middle East and Africa - Compounding Pharmacy Market Value Share Analysis, By Dosage Form, 2023 and 2034
Figure 107: Middle East and Africa - Compounding Pharmacy Market Attractiveness Analysis, By Dosage Form, 2024-2034
Figure 108: Middle East and Africa - Compounding Pharmacy Market Value Share Analysis, By Application, 2023 and 2034
Figure 109: Middle East and Africa - Compounding Pharmacy Market Attractiveness Analysis, By Application, 2024-2034
Figure 110: Middle East and Africa - Compounding Pharmacy Market Value Share Analysis, By Patient Demographics, 2023 and 2034
Figure 111: Middle East and Africa - Compounding Pharmacy Market Attractiveness Analysis, By Patient Demographics, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Compounding Pharmacy Market
